Fibrokistik mastopati tedavisinde bromokriptine ve tiroid hormonunun etkisi

dc.contributor.buuauthorBozgül, Mustafa
dc.contributor.buuauthorBilgel, Halil
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Cerrahi Anabilim Dalı.tr_TR
dc.date.accessioned2022-05-11T06:30:37Z
dc.date.available2022-05-11T06:30:37Z
dc.date.issued1987
dc.description.abstractFibrokistik mastopati, selim meme hastalıklarının en sık görülen formudur. Ağrı, memede nodülarite yaygın semptomları dır. Etyolojisi tam olarak bilinmemektedir. Tedavide çeşitli ilaçlar kullanılmaktadır. Her yaşta görülebilirse de en çok menopoz öncesi görülür. Kliniğimizde 50 olgu prospektif olarak incelenmiştir. Grup I Bromocriptine G. II tiroid hormon preparatı ile tedavi edilmiştir. Ortalama yaş 29.5 yıldır. Tedavide her iki ilaçla tedavi edilenlerde yaklaşık sonuçlar elde edilmiştir.tr_TR
dc.description.abstractFibrocystic mastopathy is the most common breast lesion. The most common cause of breast pain and nodularities are fibrocystic mastopathy. Pathophysiology of fibrocystic mastopathy is unknown. Miscellaneous drugs have been used for treatment of fibrocystic mastopathy. It occurs around the menopause but can occur at any age. In this article, fifty patients with fibrocystic mastopathy were selected. The patients were treated with Bromocriptine and thyroid hormone. The mean age was 29.5 years. These studies have shown similar results in the treatment of fibrocystic mastopathy with Bromocriptine and thyroid hormone.en_US
dc.identifier.citationBozgül, M. ve Bilgel, H. (1987). ''Fibrokistik mastopati tedavisinde bromokriptine ve tiroid hormonunun etkisi''. Uludağ Üniversitesi Tıp Fakültesi Dergisi, 14(2), 99-104.tr_TR
dc.identifier.endpage104tr_TR
dc.identifier.issue2tr_TR
dc.identifier.startpage99tr_TR
dc.identifier.urihttp://hdl.handle.net/11452/26372
dc.identifier.volume14tr_TR
dc.language.isotrtr_TR
dc.publisherUludağ Üniversitesitr_TR
dc.relation.journalUludağ Üniversitesi Tıp Fakültesi Dergisitr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectFibrokistik mastopati tedavisitr_TR
dc.subjectBromokriptinetr_TR
dc.subjectTiroid hormonunutr_TR
dc.subjectThyroid hormoneen_US
dc.subjectTreatment of fibrocystic mastopathyen_US
dc.subjectBromocriptineen_US
dc.titleFibrokistik mastopati tedavisinde bromokriptine ve tiroid hormonunun etkisitr_TR
dc.title.alternativeEffects of bromocriptine and tyroid hormone in the treatment of fibrocystic mastopathyen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
14_2_2.pdf
Size:
1.16 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: